Contribution of allelic variations in transporters to the phenotype of drug response

Journal of Psychopharmacology

Volumn 20, Issue 4 SUPPL., 2006, Pages 27-32

  Kirchheiner, Julia ^a   Gründemann, Dirk ^b   Schömig, Edgar ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antidepressant; Antipsychotic; Neurotransmitter; Pharmacogenetics; Response; Transporter

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; DESIPRAMINE; DOPAMINE TRANSPORTER; GLYCOPROTEIN P; LOFEPRAMINE; MAPROTILINE; MIRTAZAPINE; MULTIDRUG RESISTANCE PROTEIN 1; NEUROLEPTIC AGENT; NORADRENALIN TRANSPORTER; OXAPROTILINE; PAROXETINE; REBOXETINE; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE; VILOXAZINE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; ARTICLE; BLOOD BRAIN BARRIER; CORRELATION ANALYSIS; DNA POLYMORPHISM; DRUG RESPONSE; GENE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; NET G1287A GENE; NEUROTRANSMISSION; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REGULATOR GENE; SLCA6 GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; HUMANS; MODELS, BIOLOGICAL; NEUROTRANSMITTER TRANSPORT PROTEINS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 33750042579     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806066043     Document Type: Article

References (45)

1. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, di Bella D, Smeraldi E (1999) Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 156(9): 1450-1452
2. Byerley W, Coon H, Hoff M, Holik J, Waldo M, Freedman R, Caron M G, Giros B (1993) Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees. Hum Hered 43(5): 319-322
3. Chong S A, Tan E C, Tan C H, Mahendren R, Tay A H, Chua H C (2000) Tardive dyskinesia is not associated with the serotonin gene polymorphism (5-HTTLPR) in Chinese. Am J Med Genet 96(6): 712-715
4. De Luca V, Mundo E, Trakalo J, Wong G W, Kennedy J L (2003) Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics J 3(5): 297-299
5. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 1(2): 152-156
6. Georgieva L, Dimitrova A, Nikolov I, Koleva S, Tsvetkova R, Owen M J, Toncheva D, Kirov G (2002) Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population. Acta Psychiatr Scand 105(5): 396-399
7. Gorman J M, Sullivan G (2000) Noradrenergic approaches to antidepressant therapy. J Clin Psychiatry 61(Suppl 1): 13-16
8. Greenwood T A, Alexander M, Keck P E, McElroy S, Sadovnick A D, Remick R A Kelsoe J R (2001) Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105(2): 145-151
9. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D K, Lesch P (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66(6): 2621-2624
10. Hoffmeyer S, Burk O, von Richter O, Arnold H P, Brockmöller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97(7): 3473-3478
11. Hong C J, Lin C H, Yu Y W, Yang K H, Tsai S J (2001) Genetic variants of the serotonin system and weight change during clozapine treatment. Pharmacogenetics 11(3): 265-268
12. Ichikawa J, Meltzer H Y (1995) Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmacol 281(3): 255-261
13. Ito K, Yoshida K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K (2002) A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. Psychiatry Res 111(2-3): 235-239
14. Kaiser R, Tremblay P B, Schmider J, Henneken M, Dettling M, Muller-Oerlinghausen B, Uebelhack R, Roots I, Brockmöller J (2001) Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psychiatry 6(2): 179-185
15. Kim D K, Lim S W, Lee S, Sohn S E, Kim S, Hahn C G, Carroll B J (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11(1): 215-219
16. Kim J Y, Jung I, Han K C, Cho S H, Kim L, Kim S H, Lee B H, Lee H J, Kim Y K (2005) Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 59(2): 183-188
17. Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockmöller J (2006) A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. The Pharmacogenomics Journal, in press
18. Kugaya A, Seneca N M, Snyder P J, Williams S A, Malison R T, Baldwin R M, Seibyl J P, Innis R B (2003) Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28(2): 413-420
19. Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T, Hirose T, Nanko S (1997) Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2(6): 457-462
20. Lesch K P, Bengel D, Heils A, Sabol S Z, Greenberg B D, Petri S, Benjamin J, Muller C R, Hamer D H, Murphy D L (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292): 1527-1531
21. Leszczynska-Rodziewicz A, Czerski P M, Kapelski P, Godlewski S, Dmitrzak-Weglarz M, Rybakowski J, Hauser J. (2002) A polymorphism of the norepinephrine transporter gene in bipolar disorder and schizophrenia: lack of association. Neuropsychobiology 45(4): 182-185
22. MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 96(26): 15251-15255
23. Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B, Hallmayer J, Fimmers R, Ackenheil M, Ebstein R E, Borrmann M, Lichtermann D, Wildenauer D B (1996) Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association. Schizophr Res 20(1-2): 175-180
24. Mill J, Asherson P, Craig I, D'Souza U M (2005) Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet 6(1): 3
25. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114(8): 975-979
26. Miller G M, Madras B K (2002) Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 7(1): 44-55
27. Murphy D L, Lerner A, Rudnick G, Lesch K P (2004) Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv 4(2): 109-123
28. Murphy G M, Jr., Hollander S B, Rodrigues H E, Kremer C, Schatzberg A F (2004) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61(11): 1163-1169
29. Ozdemir V, Kalow W, Okey A B, Lam M S, Albers L J, Reist C, Fourie J, Posner P, Collins E J, Roy R (2001) Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C→A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine. J Clin Psychopharmacol 21(6): 603-607
30. Pollock B G, Ferrell R E, Mulsant B H, Mazumdar S, Miller M, Sweet R A, Davis S, Kirshner M A, Houck P R, Stack J A, Reynolds C F, Kupfer D J (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23(5): 587-590
31. Rausch J L, Johnson M E, Fei Y J, Li J Q, Shendarkar N, Hobby H M, Ganapathy V, Leibach F H (2002) Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol Psychiatry 51(9): 723-732
32. Roberts R L, Joyce P R, Mulder R T, Begg E J, Kennedy M A (2002) A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J 2(3): 191-196
33. Roy A, Pickar D, Linnoila M, Doran A R, Ninan P, Paul S M (1985) Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res 15(4): 281-292
34. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3(6): 508-511
35. Smith T D, Kuczenski R, George-Friedman K, Malley J D, Foote S L (2000) In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration. Synapse 38(4): 460-470
36. Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, Janka Z (2004) Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 124(1): 1-5
37. Tsai S J, Hong C J, Yu Y W, Lin C H, Song H L, Lai H C, Yang K H (2000) Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophr Res 44(3): 177-181
38. Uhr M, Grauer M T, Holsboer F (2003) Differential enhancement of anti-depressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry 54(8): 840-846
39. Waldman I D, Robinson B F, Feigon S A (1997) Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity. Genet Epidemiol 14(6): 699-704
40. Whale R, Quested D J, Laver D, Harrison P J, Cowen P J (2000) Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berl) 150(1): 120-122
41. Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, Shimizu T, Itoh K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K, Otani K (2002) Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 26(2): 383-386
42. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, Naito S, Shimizu T, Itoh K, Inoue K, Suzuki T, Nemeroff C B (2004) Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 161(9): 1575-1580
43. Yu Y W, Tsai S J, Chen T J, Lin C H, Hong C J (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7(10): 1115-1119
44. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 20(1): 105-107
45. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, Dotoli D, Smeraldi E (2001) Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and non-delusional depression. Biol Psychiatry 50(5): 323-330